KRYS
Krystal Biotech Inc
345.00$
+0.9%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +392.6% | +7.4% | +55.3% | +19.3% | +8.7% | -3.2% | +8.9% | +1.8% | +9.5% | +8.6% | +2.5% | – | |
| – | +1,863.2% | -44.7% | +148.4% | +11.2% | -26.0% | +1.6% | +42.5% | -21.0% | +92.8% | -42.1% | +1.8% | – | |
| – | +353.2% | +13.4% | +50.1% | +20.0% | +11.7% | -3.5% | +6.9% | +3.7% | +4.4% | +14.4% | +2.5% | – | |
| – | +7.0% | -3.6% | +42.2% | -13.3% | +0.1% | +5.4% | +1.1% | -8.5% | +22.8% | -5.3% | -5.3% | – | |
| – | +210.7% | -64.6% | +6.0% | +3.9% | +9.0% | +4.6% | +7.4% | +6.9% | +10.3% | -1.0% | -2.8% | – | |
| – | +0.9% | +43.0% | +12.5% | -1.8% | -18.1% | +4.8% | +5.5% | +2.4% | +1.9% | +8.9% | -3.5% | – | |
| – | – | -313.0% | – | +161.9% | +84.5% | -12.6% | +8.7% | +5.3% | +7.4% | +20.8% | +8.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -86.8% | -91.3% | +1,621.6% | +85.5% | +63.3% | -10.3% | +7.3% | +2.5% | +6.6% | +20.2% | +7.5% | – | |
| – | – | +148.5% | -90.2% | +442.8% | +20.9% | +151.2% | +7.3% | -471.9% | – | – | +105.3% | – | |
| – | -89.2% | -89.3% | +1,570.4% | +74.6% | +67.3% | -21.4% | +7.3% | +107.0% | -35.2% | +8.8% | -2.1% | – | |
| – | -85.2% | -39.0% | +210.9% | +57.9% | +37.6% | -9.8% | +6.8% | +2.6% | -20.1% | +59.5% | +4.6% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.